CIPLA
Back to Income Statement
|
CIPLA Last 5 Year Appropriations History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Appropriations | ₹22,179 Cr | ₹18,471 Cr | ₹16,054 Cr | ₹13,523 Cr | ₹11,798 Cr |
What is the latest Appropriations of CIPLA ?
Year | Appropriations |
---|---|
Mar2024 | ₹22,179 Cr |
Mar2023 | ₹18,471 Cr |
Mar2022 | ₹16,054 Cr |
Mar2021 | ₹13,523 Cr |
Mar2020 | ₹11,798 Cr |
How is Appropriations of CIPLA Trending?
Years | Appropriations | % Change | |
---|---|---|---|
Mar2024 | ₹22,179 Cr | 20.07 | |
Mar2023 | ₹18,471 Cr | 15.06 | |
Mar2022 | ₹16,054 Cr | 18.72 | |
Mar2021 | ₹13,523 Cr | 14.62 | |
Mar2020 | ₹11,798 Cr | - |
Compare Appropriations of peers of CIPLA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CIPLA | ₹133,407.4 Cr | -0.3% | 5.7% | 36.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹439,714.0 Cr | -1.7% | 3.8% | 62.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹145,166.0 Cr | -0.2% | 15.8% | 45.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,604.0 Cr | -1.7% | -5.7% | 15.5% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹108,608.0 Cr | -3.6% | -9.5% | 72.6% | Stock Analytics | |
MANKIND PHARMA | ₹96,024.4 Cr | -1.5% | 1.6% | 35.5% | Stock Analytics |
CIPLA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CIPLA | -0.3% |
5.7% |
36.1% |
SENSEX | 1.8% |
3.1% |
23.4% |
You may also like the below Video Courses